Cabrera-GarcÃa et al., 2016 - Google Patents
Gd-Si oxide nanoparticles as contrast agents in magnetic resonance imagingCabrera-GarcÃa et al., 2016
View HTML- Document ID
- 5964160860559223412
- Author
- Cabrera-GarcÃa A
- Vidal-Moya A
- Bernabeu Ã
- Pacheco-Torres J
- Checa-Chavarria E
- Fernández E
- Botella P
- Publication year
- Publication venue
- Nanomaterials
External Links
Snippet
We describe the synthesis, characterization and application as contrast agents in magnetic resonance imaging of a novel type of magnetic nanoparticle based on Gd-Si oxide, which presents high Gd3+ atom density. For this purpose, we have used a Prussian Blue analogue …
- 239000002105 nanoparticle 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Caspani et al. | Magnetic nanomaterials as contrast agents for MRI | |
| Fernández-Barahona et al. | Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging | |
| Mittal et al. | Magnetic nanoparticles: An overview for biomedical applications | |
| Mrówczyński et al. | Cyclodextrin-based magnetic nanoparticles for cancer therapy | |
| Ferreira et al. | The role of magnetic nanoparticles in cancer nanotheranostics | |
| Liu et al. | 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics | |
| Zhu et al. | Nanoparticle-based systems for T 1-weighted magnetic resonance imaging contrast agents | |
| Bao et al. | Multifunctional Hf/Mn-TCPP metal-organic framework nanoparticles for triple-modality imaging-guided PTT/RT synergistic cancer therapy | |
| Jarockyte et al. | Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals | |
| Hu et al. | Facile synthesis of hyaluronic acid-modified Fe 3 O 4/Au composite nanoparticles for targeted dual mode MR/CT imaging of tumors | |
| Usman et al. | Graphene oxide as a nanocarrier for a theranostics delivery system of protocatechuic acid and gadolinium/gold nanoparticles | |
| Feng et al. | Surfactant-free aqueous synthesis of novel Ba2GdF7: Yb3+, Er3+@ PEG upconversion nanoparticles for in vivo trimodality imaging | |
| Kozenkova et al. | Multifunctional Fe3O4-Au nanoparticles for the MRI diagnosis and potential treatment of liver cancer | |
| Cabrera-GarcÃa et al. | Gd-Si oxide nanoparticles as contrast agents in magnetic resonance imaging | |
| Sani Usman et al. | Gadolinium-doped gallic acid-zinc/aluminium-layered double hydroxide/gold theranostic nanoparticles for a bimodal magnetic resonance imaging and drug delivery system | |
| Llenas et al. | Microwave-assisted synthesis of SPION-reduced graphene oxide hybrids for magnetic resonance imaging (MRI) | |
| Lartigue et al. | Luminophore and magnetic multicore nanoassemblies for dual-mode MRI and fluorescence imaging | |
| Li et al. | The renal clearable magnetic resonance imaging contrast agents: state of the art and recent advances | |
| Ziemian et al. | Optimization of iron oxide tracer synthesis for magnetic particle imaging | |
| Zhan et al. | In vivo dual-modality fluorescence and magnetic resonance imaging-guided lymph node mapping with good biocompatibility manganese oxide nanoparticles | |
| Gowtham et al. | Alginate-derivative encapsulated carbon coated manganese-ferrite nanodots for multimodal medical imaging | |
| Yu et al. | Achieving effective multimodal imaging with rare-earth ion-doped CaF2 nanoparticles | |
| Chauhan et al. | Targeted gold nanoparticle–oligonucleotide contrast agents in combination with a new local voxel-wise MRI analysis algorithm for in vitro imaging of triple-negative breast cancer | |
| Yu et al. | Multifunctional layered double hydroxides for drug delivery and imaging | |
| Jiménez Sánchez et al. | Fluorescent radiosensitizing gold nanoparticles |